Childhood Asthma Mentoring Program for Parents (CAMPP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02747706|
Recruitment Status : Unknown
Verified April 2016 by Ashwin Patel, InquisitHealth, Inc..
Recruitment status was: Recruiting
First Posted : April 22, 2016
Last Update Posted : April 22, 2016
There are 7.1 million children with asthma. Asthma is the cause of 10.5 million missed days of school, 7.5 million outpatient visits, 640,000 ED visits, and 157,000 hospitalization visits in 2008. Recent work has demonstrated that trained peer mentors (individuals from the community) can be effective in reducing hospitalizations for asthmatic children.
This study will evaluate the efficacy of technology-driven parent-to-parent mentoring to reduce asthma-related pediatric hospitalizations and emergency department visits.
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Behavioral: Parent-to-parent mentoring||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||240 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Peer Mentor Training to Reduce Hospitalizations for Children With Asthma|
|Study Start Date :||April 2016|
|Estimated Primary Completion Date :||September 2017|
|Estimated Study Completion Date :||March 2018|
Experimental: Parent Mentoring
1-on-1, phone, SMS/text, and smartphone-based parent-to-parent mentoring.
Behavioral: Parent-to-parent mentoring
phone, SMS/text, and smartphone-based support
No Intervention: Usual Care
No intervention through study.
- Number of hospital admissions [ Time Frame: 1-year ]
- Number of emergency department visits [ Time Frame: 1-year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02747706
|Contact: Ashwin Patel, MD PhDemail@example.com|
|United States, New Jersey|
|River Edge, New Jersey, United States, 07661|
|Contact: Ashwin Patel, MD PhD 855-412-1787 firstname.lastname@example.org|
|Principal Investigator:||Ashwin Patel, MD PhD||Chief Medical Officer|